Federal Register of Legislation - Australian Government

Primary content

PB 77 of 2021 Determinations/Health as made
This instrument amends the National Health (Continued Dispensing – Emergency Measures) Determination 2020 which specifies the pharmaceutical benefits that can be supplied by an approved pharmacist under Part VII of the National Health Act 1953 without a prescription, and the conditions for such a supply (‘Continued Dispensing’).
Administered by: Health
Registered 31 Jul 2021
Tabling HistoryDate
Tabled HR03-Aug-2021
Tabled Senate03-Aug-2021
Date of repeal 19 Oct 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 77 of 2021

 

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 7)

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.

Dated               27 July             2021

 

 

 

 

           

NIKOLAI TSYGANOV                 

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

                                           


 

 

Contents

1...... Name

2...... Commencement............................................................................................................................... 1

3...... Authority......................................................................................................................................... 1

4 ..... Schedule.......................................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

 

 

 


1  Name

(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 7).

(2) This instrument may also be cited as PB 77 of 2021.

2  Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 August 2021

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]        Schedule 1, after entry for Adrenaline (epinephrine) in the form Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)

insert:

 

Solution for injection 1 mg (as tartrate) in 1 mL (1 in 1,000)

Injection

[2]        Schedule 1, after entry for Alendronic acid with colecalciferol and calcium

insert:

Alirocumab

Injection 75 mg in 1 mL single use pre-filled pen

Injection

 

Injection 150 mg in 1 mL single use pre-filled pen

Injection

[3]        Schedule 1, entry for Exenatide

            omit:

 

Injection (modified release) 2 mg single dose pre-filled pen

Injection

[4]        Schedule 1, after entry for Framycetin

insert:

Fremanezumab

Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe

Injection

[5]        Schedule 1, entry for Paraffin

insert as first entry:

 

Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer-188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free)

Application to the eye